共 50 条
- [2] Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I614 - I615
- [6] T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 (02): : 251 - 258
- [7] SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S564 - S564
- [8] Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease [J]. Aging Clinical and Experimental Research, 2021, 33 : 2355 - 2359
- [10] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection [J]. Molecular Biology Reports, 2021, 48 : 5745 - 5758